|  | FTLD subgroups |  |  | |||
---|---|---|---|---|---|---|---|
 |  |  |  | FTLD-TDP subgroups |  |  | |
 | FTLD | FTLD-tau | FTLD-TDP | FTLD-C9orf72 | FTLD-GRN | Controls | Alzheimer’s disease |
Gender, % male/female (n) | 50/50 (46) | 70/30 (10) | 44/56 (34) | 37/63 (19) | 56/44 (9) | 55/45 (20) | 49/51 (45) |
Age at LP (years) | 63.6 (55.1–71.7)a | 70.3 (56.2–74.4) | 63.3 (54.5–71.6) | 59.0 (53.7–69.5)* | 67.3 (63.3–71.9) | 69.4 (61.5–74.7) | 71.2 (66.7–79.2) |
Age at onset (years) | 62.0 (53.8–69.2)a | 56.0 (54.0–71.0) | 63.5 (52.8–69.2) | 56.0 (48.0–67.0) | 66.0 (61.5–70.0) | N/A | 69.5 (64.3–75.8) |
Age at death (years) | 65.9 (60.2–75.1) | 74.0 (60.8–76.2) | 62.9 (57.5–72.5) | 57.7 (52.3–62.6)*†| 69.1 (61.1–74.2) | N/A | N/A |
APOE ε4 carriers, % (n) | 32.4 (37) | 57.1 (7) | 27.6 (29) | 30.8 (13) | 20.0 (10) | 33.3 (6) | 59.5 (42) |
MMSE at LP (0–30), (n) | 21 (15–25) (29) | 23 (22–27) (5) | 19 (14–25) (23) | 15 (7–21) (10)†| 23 (16–26) (7) | N/A | 20 (15–25) (42) |
Serum progranulin (ng/mL) | 95 (60–126)a,b | 96 (76–167)* | 95 (61–125) | 107 (91–125)* | 48 (39–63) | 130 (101–175) | 119 (98–145) |
CSF progranulin (ng/mL) | 3.39 (2.29–3.85)a | 3.79 (2.94–4.23)* | 3.00 (2.10–3.64) | 3.21 (2.35–3.74)* | 1.93 (0.97–2.43) | 3.61 (2.92–4.50) | 3.88 (3.22–4.59) |
CSF Aβ1–42 (pg/mL) | 641 (457–858)a | 543 (438–960) | 698 (481–862) | 695 (457–819) | 708 (578–943) | 812 (646–1108) | 509 (372–594)b |
CSF t-tau (pg/mL) | 320 (219–420)a | 331 (197–400) | 330 (236–464) | 252 (178–332)* | 379 (296–559) | 257 (173–381) | 627 (429–928)b |
CSF p-tau181 (pg/mL) | 36.7 (28.3–49.0)a | 35.5 (26.9–58.8) | 37.2 (28.8–49.0) | 33.0 (22.0–49.0) | 36.0 (30.9–42.5) | 40.3 (32.9–58.6) | 80.0 (60.5–105.0)b |
CSF p-tau181/t-tau ratio | 0.117 (0.097–0.149)b | 0.144 (0.095–0.152)* | 0.116 (0.092–0.145) | 0.142 (0.105–0.164)* | 0.088 (0.076–0.114) | 0.176 (0.156–0.197) | 0.132 (0.104–0.149)b |
CSF Nf-L (pg/mL) | 3967 (2556–7148)a,b | 2508 (1217–6053)* | 4323 (3367–7358) | 3446 (2611–4049)* | 7323 (5432–9097) | 1136 (547–3984) | 1597 (1281–2781) |
CSF pNf-H (ng/mL) | 0.43 (0.21–1.25) | 0.54 (0.29–1.45)* | 0.41 (0.16–0.95) | 0.45 (0.22–0.95)* | 0.04 (0.04–0.33) | 0.33 (0.04–1.36) | 0.47 (0.19–1.43) |